Synthetic polysaccharide antigens for immunological intervention in disease

Details for Australian Patent Application No. 2011203013 (hide)

Owner Eli Lilly and Company

Inventors Kraft, Angelika Regina; Cohen, Charles Ellis; Cleveland Jr., John Astor; Taylor, Kathleen Ann; Blaszczak, Larry Chris; Blackburn, Neil Thomas

Agent Spruson & Ferguson

Pub. Number AU-A-2011203013

Parent 2004280329

Filing date 21 June 2011

Wipo publication date 14 July 2011

International Classifications

C07K 9/00 (2006.01) Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

C08B 37/00 (2006.01) Preparation of polysaccharides not provided for in

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

7 July 2011 Complete Application Filed

14 July 2011 Application Open to Public Inspection

  Published as AU-A-2011203013

13 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application was refused. Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011203014-System and method for controlled market data delivery in an electronic trading environment

2011203012-Tuberculosis vaccines comprising antigens expressed during the latent infection phase